Streamlined IRB Review and Multi-Institutional Studies

 

Harvard Catalyst has developed a resource that may be very useful to investigators who are conducting studies across institutions. The Reciprocal Common IRB Reliance Agreement will allow investigators who are proposing multi-institutional studies to request “ceded review,” that is to request that the IRBs on a multi-institutional study rely on the review of one IRB for that particular study.  This agreement should help facilitate and minimize negotiation and review between the participating IRBs as long as the institutions agree that ceded review is appropriate for a given protocol. The ceded review form is available on the HSPH Office of Regulatory Affairs and Research Compliance Website.

Participating institutions include:

Harvard School of Public Health
Harvard Medical School
Harvard University FAS
Beth Israel Deaconness Medical Center
Brigham and Women’s Hospital
Children’s Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Massachusetts General Hospital